Gland Pharma has received USFDA approval for its Zoledronic Acid Injection, a bisphosphonate used to treat osteoporosis, Paget’s disease, and bone complications from cancer. This milestone strengthens Gland Pharma’s U.S. portfolio, enhancing global credibility and expanding access to advanced therapies for bone health management.
Show moreStay Ahead – Explore Now! HCLTech Partners with HAESL to Digitally Transform Aviation Maintenance
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
